sanofi-aventis US recalls
sanofi-aventis US has 3 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 2 Jan 2013. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls3since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jan 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why sanofi-aventis us is recalled
Product types
By year
All sanofi-aventis us recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Diamigo i-Phone App The Diamigo app was intended recalled | sanofi-aventis US | Device Malfunction | NJ |
| Drug | CLASS II | Eloxatin (OXALIplatin injection) 5 mg/mL injection, 100 mg recalled | sanofi-aventis US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Eloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg recalled | sanofi-aventis US | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.